STEM-28. NANOPARTICLES ENCAPSULATING A CONNEXIN43 MIMETIC PEPTIDE LIMIT GLIOMA STEM CELL SURVIVAL AND GLIOBLASTOMA PROGRESSION

Glioblastoma (GBM) is the most common and aggressive primary adult brain tumor in the US. The current treatment regimen for GBM still retains an alarmingly poor prognosis, with median survival of only 14.6 months. Failure to generate more effective treatment strategies is due to the infiltrative nat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Will, John, Thompson, Emily, Harrigan, Megan, Smyth, James, Sheng, Zhi, Gourdie, Robert, Sontheimer, Harry, Foster, Johan, Lamouille, Samy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Cancer Stem Cells
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651682/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.845
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia